Momchilo Vuyisich, PhD
Viome founding CSO who developed the Los Alamos RNA metatranscriptomics platform behind its testing line
Practice
About
Momo Vuyisich, PhD is Viome's Founding Chief Science Officer and Head of Clinical Research, and one of the scientists behind the company's core RNA metatranscriptomic platform. He earned his PhD from the University of Utah in RNA biochemistry, then spent more than a decade at Los Alamos National Laboratory developing the technology Viome commercialized. His publication record includes Viome's salivary metatranscriptome cancer-detection work and population-scale metatranscriptomic platform validation.
Approach
Signature approach
Vuyisich's scientific frame is RNA gene expression as a live readout of biology. At Viome, that means reading active signals from bacteria, viruses, fungi, archaea, and human cells across stool, saliva, and blood, then using the same metatranscriptomic pipeline for wellness reports and CancerDetect.
What sets them apart
- Platform originator. The metatranscriptomics technology Viome commercialized was developed through his Los Alamos work before company launch.
- Published Viome science. His Scholar profile includes the salivary metatranscriptome cancer-detection papers and population-scale metatranscriptomics validation work.
- RNA-first career. His PhD work centered on RNA biochemistry, giving Viome's platform a long scientific through-line.
Focus
Specialties
Training
Education
- PhD, Chemistry / RNA biochemistryUniversity of Utah (Beal Lab) (2002)
- BS, MicrobiologyUniversity of Texas at El Paso (1997)
Published work
Publications
- Microbiome, 2023
- NPJ Genomic Medicine, 2021
- International Journal of Genomics, 2019
- Oral Oncology, 2023
- Diabetes Therapy, 2022
- BioTechniques, 2020
- Scientific Reports, 2025
- Computational and Structural Biotechnology Journal, 2024
- Microorganisms, 2026
Elsewhere
Media and talks
- Phase Genomics
- Outliyr Podcast · 2026-04-15
- High Performance Longevity / Outliyr · 2026-04
- HealCircle · 2019-08
- Phase Genomics / Genome Startup Day
Collaboration
- Naveen JainViome co-founder & CEO — serial entrepreneur (Moon Express, Intelius, Infospace) who funded the LANL-to-Viome platform commercialization
- Guruduth Banavar, PhDViome co-founder & Founding CTO — former IBM Research VP and Watson AI lead; co-leads clinical research with Vuyisich and is first author on Viome's salivary metatranscriptome cancer-detection papers
Profiles
Verification
- Profile updated
Primary sourcehttps://www.viome.com/company
Where a detail is missing, it means we have not verified it—not that the answer is no. Directory listings are for informational purposes only. Inclusion does not constitute endorsement. Verify credentials and qualifications independently.